Connection

Marco Massari to Italy

Back to Details
This is a "connection" page, showing publications Marco Massari has written about Italy.
Marco Massari
Connection Strength
0.163
Italy
  1. Abdominal Visceral Infarction in 3 Patients with COVID-19. Emerg Infect Dis. 2020 Aug; 26(8):1926-1928.
    View in: PubMed
    Score: 0.037
  2. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy. Rheumatology (Oxford). 2021 10 09; 60(SI):SI25-SI36.
    View in: PubMed
    Score: 0.010
  3. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021. Euro Surveill. 2021 Jun; 26(25).
    View in: PubMed
    Score: 0.010
  4. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS One. 2021; 16(5):e0251768.
    View in: PubMed
    Score: 0.010
  5. Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy. Eur Addict Res. 2021; 27(4):263-267.
    View in: PubMed
    Score: 0.010
  6. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):24-31.
    View in: PubMed
    Score: 0.010
  7. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients. Drug Saf. 2020 12; 43(12):1297-1308.
    View in: PubMed
    Score: 0.010
  8. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
    View in: PubMed
    Score: 0.009
  9. Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy. Eur Radiol. 2020 Dec; 30(12):6818-6827.
    View in: PubMed
    Score: 0.009
  10. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study. Ann Rheum Dis. 2020 07; 79(7):986-988.
    View in: PubMed
    Score: 0.009
  11. The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort. Dig Liver Dis. 2019 03; 51(3):438-442.
    View in: PubMed
    Score: 0.008
  12. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? Liver Int. 2018 12; 38(12):2190-2198.
    View in: PubMed
    Score: 0.008
  13. The potential impact of multidimesional geriatric assessment in the social security system. Aging Clin Exp Res. 2018 Oct; 30(10):1225-1232.
    View in: PubMed
    Score: 0.008
  14. What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group. Infez Med. 2017 Jun 01; 25(2):150-157.
    View in: PubMed
    Score: 0.007
  15. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study. PLoS One. 2017; 12(2):e0172159.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.